Senior insider sale
EVP, Business Development at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$680.3K
18.60K shares
What this filing means
LIPPMAN EVAN plans to sell 18.60K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $680.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001973379-26-000296
Officer· EVP, Business Development
Since Mar 2026
18.60K
Shares to sell
$680.3K
Approx. market value
18.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares from Rollover, ADR
COMPENSATION
5/14/2026
18.60KTotal acquired18.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/14/2026 | Shares from Rollover, ADR COMPENSATION | 18.60K | — |
| Total | 18.60K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
18.60K
Market value
$680.3K
8/17/2026
Total
Units
18.60K
Value
$680.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 18.60K | $680.3K | NYSE | Planned |
| Total | 18.60K | $680.3K | ||